Skip to content
healthcare.dev

Nevirapine

NDC 65862-057, Nevirapine, suspension, from Aurobindo Pharma Limited.

Product NDC
65862-057
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077702
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65862-057 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NEVIRAPINE HEMIHYDRATE50 mg/5mL

Pharmacologic classes

Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 3A Inducers [MoA]; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Non-Nucleoside Analog [EXT]; Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]

Package NDCNDC-11Package
65862-057-1165862005711100 mL in 1 BOTTLE (65862-057-11)
65862-057-2465862005724240 mL in 1 BOTTLE (65862-057-24)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/8dfe86aa-ea5d-48d2-94a8-1a5506055d70

Use it

Look up 65862-057 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65862-057 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65862-057. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.